IP Law 360

MAY 23, 2022

Bristol-Myers Squibb is asking a New York court to enforce an award it won in a dispute with Swiss pharmaceutical company Novartis Pharma AG over royalties owed for its use of patented "transgenic" mice to develop therapeutic drugs.

Patent 40

Patent 40

LexBlog IP

AUGUST 11, 2021

AOVM Companies. Novartis AG. North American Marketing, Inc. POLYPHENOL-C. Gallo Winery. RL Brands, LLC. Bloomberg L.P. El Cinco, Inc. Radix IoT, LLC. Radix DLT Limited. Washington Wine Group. Luxco, Inc. Fleet Associates. Reliance Worldwide. HEAVEN’S ARMOR. Under Armour, Inc. FCA US LLC. N Squared Technologies.

Branding 52

Branding Brands Branding Trademark 52

The IPKat

APRIL 5, 2023

In Neurim Pharmaceuticals (1991) Ltd and another company v Generics UK Ltd and another [2020] EWHC 3270 (Pat), Neurim was successful on all issues. Desserts 7) Arrow Meringue In Teva v Novartis [2022] EWHC 2779 (Ch) questions arose as to whether Arrow declarations are appropriate if a party has de-designated its patent in the UK.

Reporting 73

Reporting Patent Patent Infringement Technology 73

IP and Legal Filings

MAY 13, 2022

The present case deals with the compulsory license awarded to a domestic generic pharmaceutical private company, Natco, for the manufacture and sale of the kidney cancer drug Nexavar, patented by Bayer Corporation in India. This notion is also evident from cases like Novartis AG v.

Licensing 52

Licensing Government Invention Patent 52

IP Tech Blog

AUGUST 18, 2023

In Novartis AG v. Novartis v. declaration against Novartis’s patent ZL201080051819.0 (“ZL819”) related to Tasigna (nilotinib hydrochloride). Novartis AG v. Novartis v. declaration against Novartis’ three patents ZL200780004302.4, Recent Patent Linkage Litigations Since Chugai v. AstraZeneca v.

Litigation 98

Litigation Patent Intellectual Property Branding 98

LexBlog IP

AUGUST 18, 2023

In Novartis AG v. Ltd. (“Novartis v. declaration against Novartis’s patent ZL201080051819.0 (“ZL819”) related to Tasigna (nilotinib hydrochloride). Novartis AG v. Ltd. (“Novartis v. declaration against Novartis’ three patents ZL200780004302.4,

Litigation 52

Litigation Patent Intellectual Property Branding 52

IP and Legal Filings

AUGUST 14, 2023

7] To simply if State X is a signatory to either of the conventions and Company A registered in State P has filled an IPR infringement case in State X against a citizen of State X, State has to treat Company A as its own national and not favour the alleged tort feasor.

Copyright Infringement 52

Copyright Infringement Law Copyright Intellectual Property 52